375 related articles for article (PubMed ID: 32013844)
1. Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies.
Furkan M; Khan RH
Curr Protein Pept Sci; 2020; 21(6):573-583. PubMed ID: 32013844
[TBL] [Abstract][Full Text] [Related]
2. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
Moreno-Gonzalez I; Soto C
Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
[TBL] [Abstract][Full Text] [Related]
3. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
Chiti F; Dobson CM
Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
[TBL] [Abstract][Full Text] [Related]
4. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
Marrero-Winkens C; Sankaran C; Schätzl HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
[TBL] [Abstract][Full Text] [Related]
5. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Maiti P; Manna J; Veleri S; Frautschy S
Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
[TBL] [Abstract][Full Text] [Related]
6. Structure and function of the molecular chaperone Hsp104 from yeast.
Grimminger-Marquardt V; Lashuel HA
Biopolymers; 2010 Mar; 93(3):252-76. PubMed ID: 19768774
[TBL] [Abstract][Full Text] [Related]
7. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
Nerelius C; Fitzen M; Johansson J
Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
[TBL] [Abstract][Full Text] [Related]
8. [Amyloidosis: a model of misfolded protein disorder].
Grateau G; Verine J; Delpech M; Ries M
Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
[TBL] [Abstract][Full Text] [Related]
9. Protein aggregation as a cause for disease.
Scheibel T; Buchner J
Handb Exp Pharmacol; 2006; (172):199-219. PubMed ID: 16610361
[TBL] [Abstract][Full Text] [Related]
10. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
11. Curcumin: A small molecule with big functionality against amyloid aggregation in neurodegenerative diseases and type 2 diabetes.
Radbakhsh S; Barreto GE; Bland AR; Sahebkar A
Biofactors; 2021 Jul; 47(4):570-586. PubMed ID: 33893674
[TBL] [Abstract][Full Text] [Related]
12. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
[TBL] [Abstract][Full Text] [Related]
13. Protein aggregation and its consequences for human disease.
Dobson CM
Protein Pept Lett; 2006; 13(3):219-27. PubMed ID: 16515449
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies.
Salahuddin P; Khan RH; Furkan M; Uversky VN; Islam Z; Fatima MT
Int J Biol Macromol; 2021 Sep; 186():580-590. PubMed ID: 34271045
[TBL] [Abstract][Full Text] [Related]
15. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of amyloid fibril formation.
Dovidchenko NV; Leonova EI; Galzitskaya OV
Biochemistry (Mosc); 2014 Dec; 79(13):1515-27. PubMed ID: 25749162
[TBL] [Abstract][Full Text] [Related]
17. Protein Misfolding Diseases.
Hartl FU
Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
Foguel D; Suarez MC; Ferrão-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly JW; Silva JL
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9831-6. PubMed ID: 12900507
[TBL] [Abstract][Full Text] [Related]
19. Chaperone-like Activity of Calnuc Prevents Amyloid Aggregation.
Kanuru M; Aradhyam GK
Biochemistry; 2017 Jan; 56(1):149-159. PubMed ID: 27997158
[TBL] [Abstract][Full Text] [Related]
20. Protein rescue from aggregates by powerful molecular chaperone machines.
Doyle SM; Genest O; Wickner S
Nat Rev Mol Cell Biol; 2013 Oct; 14(10):617-29. PubMed ID: 24061228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
